# BOLD Longevity Growth Fund

> BOLD Longevity Growth Fund is a VC fund backing Biotechnology and Medical. See 2 investments, round sizes, portfolio and contact details. Updated Oct 2026.

- Type: VC Fund
- Location: Boston, United States
- Total investments: 2
- Last investment: Oct 2026
- Lead investor: 0%
- Fund size: $58M
- Last fund: May 2024
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/company/bold-longevity-growth
- Website: https://blg.vc

BOLD Longevity Growth Fund is a VC fund in Boston focused on Biotechnology and Medical. BOLD Longevity Growth Fund invests in frontier biotechnologies that target the root causes of diseases and focus on longevity. The fund operates within the investment management sector, using private equity and venture capital to support biotechnology ventures. It seeks to contribute to the development of treatments intended to extend healthy lifespans.

## Contacts

5 contacts available for BOLD Longevity Growth Fund. Shizune tracks 4 team members at BOLD Longevity Growth Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bold-longevity-growth-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Wellness | 1 | 50% |
| Pharmaceutical | 1 | 50% |
| Machine Learning | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Sergey Young | Co-Founder | 2 | https://shizune.co/investors/profile/sergey-young |
| George Kikvadze | Limited Partner | 1 | https://shizune.co/investors/profile/george-kikvadze |
| Peter Diamandis | Co-Founder | 12 | — |
| Teymour Boutros-Ghali | Co-Founder | 12 | https://shizune.co/investors/profile/teymour-boutros-ghali |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Matchpoint Therapeutics | Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry libraryevolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology. | $150M | Series B | Oct 07, 2026 | https://matchpointtx.com/ |
| Aqtual | Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology and biochemistry for chronic disease. | $31M | Series B | Jul 10, 2025 | https://aqtual.com/ |

2 of 2 investments shown.

## Co-investors
- [Genoa Ventures](https://shizune.co/investors/profile/5-prime-ventures) — VC Fund, 1 deal together
- [Access Biotechnology](https://shizune.co/investors/profile/access-biotechnology) — VC Fund, 1 deal together
- [Atlas Venture](https://shizune.co/investors/profile/atlas-venture) — VC Fund, 1 deal together
- BB Biotech — VC Fund, 1 deal together
- [Bold Capital Partners](https://shizune.co/investors/profile/bold-capital) — VC Fund, 1 deal together
- [Digitalis Ventures](https://shizune.co/investors/profile/digitalis-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does BOLD Longevity Growth Fund invest in?

BOLD Longevity Growth Fund invests primarily in Biotechnology, Medical and Wellness startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact BOLD Longevity Growth Fund?

Public channels for BOLD Longevity Growth Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BOLD Longevity Growth Fund?

The team at BOLD Longevity Growth Fund includes Sergey Young (Co-Founder), George Kikvadze (Limited Partner) and Peter Diamandis (Co-Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co